DEXCOM G6 CONTINUOUS GLUCOSE MONITORING SYSTEM
Report
- Report Number
- 3004753838-2024-220058
- Event Type
- Malfunction
- Date Received
- August 30, 2024
- Date of Event
- July 27, 2024
- Report Date
- September 17, 2024
- Manufacturer
- DEXCOM, INC.
- Product Code
- QBJ
- PMA / PMN Number
- DEN170088
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- GB
- Reporter Occupation
- OTHER
- Health Professional
- N
Narratives
(B)(4). LABELING INDICATES: INSERTING THE SENSOR AND WEARING THE ADHESIVE PATCH MIGHT CAUSE INFECTION, BLEEDING, PAIN OR SKIN IRRITATIONS (E.G. REDNESS, SWELLING, BRUISING, ITCHING, SCARRING OR SKIN DISCOLORATION). THIS IS 2 OF 2 REPORTS OF SKIN REACTION IN WHICH EACH EVENT HAS SIMILAR DETAILS AND TREATMENT BUT OCCURRED ON TWO DIFFERENT SENSORS. PLEASE SEE RELATED RECORDS (B)(4).
(B)(4). 3004753838-2024-220058 WAS REPORTED IN ERROR. PLEASE DISREGARD INITIAL REPORTING OF THIS EVENT AS THIS EVENT HAS NOW BEEN DEEMED NOT REPORTABLE.
DEXCOM WAS MADE AWARE ON 08/02/2024, THAT ON (B)(6) 2024, THE PATIENT EXPERIENCED A SKIN REACTION. DATE OF EVENT IS AN APPROXIMATION. THE PATIENT EXPERIENCED A SKIN REACTION WITH ITCHING AND REDNESS EXTENDED BEYOND THE PATCH PERIMETER, WHICH OCCURRED AFTER THE SENSOR HAD BEEN INSERTED IN THE ARM. THIS REPORT IS TO CAPTURE THE 2ND SKIN REACTION IN WHICH EACH EVENT HAS SIMILAR DETAILS AND TREATMENT BUT OCCURRED ON TWO DIFFERENT SENSORS. PER FOLLOW UP WITH THE PATIENT ON (B)(6) 2024, THE REACTION WAS TREATED WITH A PRESCRIPTION OF ORAL MEDICATION; ANTIBIOTICS, STRONG CORTISONE, FLU FOXT 5. THE PATIENT USED OVER THE COUNTER STICKER BARRIER (CUTIDERM) AS BARRIER PRODUCT BUT IT DID NOT HELPED TO MINIMIZE OR PREVENT THE SKIN REACTION. THEY DID AN ALLERGIES TEST THAT TOOK ONE MONTH TO GIVE THE RESULT BACK, IT WAS A SUSPECTED BACTERIAL INFECTION BUT WAS NOT CONFIRMED. NO DATA OR PRODUCT WAS PROVIDED FOR INVESTIGATION. THE ALLEGATION WAS UNDETERMINED. THE PROBABLE CAUSE COULD NOT BE DETERMINED. NO ADDITIONAL EVENT OR PATIENT INFORMATION IS AVAILABLE.
SUBSEQUENT TO THE INITIAL MDR, IT WAS DETERMINED THAT A REPORT WAS SUBMITTED IN ERROR. THE ISSUE WAS ALREADY DOCUMENTED UNDER (B)(4). UPON FURTHER REVIEW, IT WAS DETERMINED THAT THE PATIENT ALLEGATION DOES NOT MEET THE CRITERIA OF A REPORTABLE EVENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1795111 | DEXCOM G6 CONTINUOUS GLUCOSE MONITORING SYSTEM | CONTINUOUS GLUCOSE MONITOR | QBJ | DEXCOM, INC. | NI |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 19 YR | Female | Other |